Skip to content
Results research

Concall Intelligence

Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search official call evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.

Open reported results
Matching calls
7
After selected filters
Transcript verified
6
Official transcript summaries on this page
Preliminary briefs
1
Presentation evidence, clearly labelled
Processing
0
Transcript filed or call source found
Tracked companies
0
Watchlist or portfolio matches

Management evidence

Generated 22 Oct, 3:13 pm IST · click a summary to inspect source-linked evidence for this results quarter.

Clear filters
CompanyCall and sourcesReported resultManagement outlookEvidence-led conclusionReview
ICICIGI
ICICI Lombard General Insurance Company Limited
Financial Services · Mid
Sept 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

ICICI Lombard General Insurance Company Limited reported robust H1 FY2027 performance, outpacing industry growth in segments like Retail Health and Commercial lines while maintaining strict underwriting discipline, though overall PBT and PAT dipped slightly and industry-wide Motor combined ratios remained heavily stressed.

Evidence summary ready
NOVARTIND
Novartis India Limited
Pharma · Small
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

Novartis India Limited is undergoing a complete commercial reset following its acquisition by ChrysCapital. The management aims to transition the company from a flattish revenue trajectory to a high-growth platform by building an internal field force of ~900 representatives, expanding distribution to 25 C&Fs and 4,000-5,000 distributors, executing strategic M&As (such as Minipress XL and ophthalmology in-licensing), and focusing on six core therapy areas.

Evidence summary ready
PARKHOTELS
Apeejay Surrendra Park Hotels Limited
Consumer · Small
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
Guidance maintained

Apeejay Surrendra Park Hotels Limited reported solid Q1 FY2027 performance with consolidated revenue up 10% YoY to Rs. 172 crores and EBITDA up 8% YoY to Rs. 52 crores, despite macroeconomic headwinds, West Asia disruptions, and subdued air traffic. Leadership in occupancy (92%) and upper upscale RevPAR was retained, while Flurys expanded to 111 outlets. Profit after tax declined 14% YoY to Rs. 12 crores due to higher finance costs for expansion and a deferred tax provision a

Evidence summary ready
RACLGEAR
RACL Geartech Limited
IT · Small
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
Guidance maintained

RACL Geartech reported robust Q1 FY27 financial performance with consolidated revenue growing 22% YoY to Rs. 132.6 crores and EBITDA expanding 18% YoY to Rs. 32.2 crores, backed by strong execution in domestic markets and resilience in European exports, particularly KTM.

Evidence summary ready
CROMPTON
Crompton Greaves Consumer Electricals Limited
Consumer · Small
Sept 2026
16 Oct 2026
Preliminary brief
Excellent
100/100
Optimistic outlook
No comparable prior call
Guidance maintained

Crompton delivered a strong Q2 FY27 performance with consolidated revenue growing 18.2% YoY to Rs 2,263.3 Cr and PAT surging 64.9% YoY to Rs 124.4 Cr. Growth was broad-based across all segments, supported by double-digit growth in ECD, robust performance in Lighting, and continued momentum in Butterfly. However, management highlighted ongoing input cost pressures from commodity inflation and an increase in net working capital due to inventory buildup.

Evidence summary ready
SOLEX
Solex Energy Limited
Power · Small
Sept 2026
8 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
New guidance

Solex Energy reported a landmark FY26 with strong top-line and bottom-line growth, backed by a robust order book and ambitious expansion plans across the solar value chain and BESS, while acknowledging the execution risks of large capital projects.

Evidence summary ready
METROBRAND
Metro Brands Limited
Consumer · Small
Sept 2026
5 Oct 2026
Transcript verified
Good
55/100
Optimistic outlook
No comparable prior call
No measurable guidance

Metro Brands Limited reported steady operational performance for FY25-26, crossing the 1,000-store milestone and posting double-digit revenue and PAT growth, though shareholders raised concerns regarding a decline in revenue per square foot and return on capital employed.

Evidence summary ready
Method: Deterministic quarterly-result score from reported growth, margin direction and operating leverage. Derived only from extracted, source-linked management evidence. Pending is shown when evidence is insufficient. Measurable claims are separated from general commentary and retain outcome status when later evidence exists. Transcript-verified summaries rank above preliminary presentation briefs and source-only call evidence. Preliminary briefs are replaced automatically when an official transcript is processed. Management outlook and colours describe extracted commentary evidence; they are not buy or sell labels.